Biogen Inc. buy UBS Group AG
Start price
08.11.23
/
50%
€216.40
Target price
08.11.24
€291.35
Performance (%)
-25.00%
End price
09.11.24
€162.30
Summary
This prediction ended on 09.11.24 with a price of €162.30. The prediction for Biogen Inc. disappointed with a performance of -25.00%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 4.939% | 4.939% | 28.182% |
| iShares Core DAX® | 1.927% | -2.112% | 11.138% |
| iShares Nasdaq 100 | -0.184% | -5.899% | -0.151% |
| iShares Nikkei 225® | 7.076% | 6.457% | 28.830% |
| iShares S&P 500 | -0.201% | -3.667% | -0.104% |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at UBS Group AG from $327.00 to $312.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten